DEUTSCHE BANK AG\ - TRANSITION THERAPEUTICS INC ownership

TRANSITION THERAPEUTICS INC's ticker is TTHI and the CUSIP is 893716209. A total of 21 filers reported holding TRANSITION THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of TRANSITION THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$2,000
-99.1%
1,802
-98.9%
0.00%
Q1 2016$216,000
-33.3%
169,4000.0%0.00%
Q4 2015$324,000
-1.8%
169,400
-8.2%
0.00%
Q3 2015$330,000
+24.1%
184,600
+45.5%
0.00%
Q2 2015$266,000
+565.0%
126,900
+2023.8%
0.00%
Q1 2015$40,000
+900.0%
5,975
+866.8%
0.00%
Q4 2014$4,000
-42.9%
618
-31.4%
0.00%
Q1 2014$7,000
-89.1%
901
-92.0%
0.00%
Q4 2013$64,000
+433.3%
11,260
+275.3%
0.00%
Q3 2013$12,0003,0000.00%
Other shareholders
TRANSITION THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 4,861,321$33,203,0004.21%
Birchview Capital, LP 150,746$1,030,0000.54%
SPHERA FUNDS MANAGEMENT LTD. 272,906$1,864,0000.19%
HOLLENCREST CAPITAL MANAGEMENT 162,196$1,108,0000.15%
DAFNA Capital Management LLC 26,410$180,0000.14%
VESTOR CAPITAL, LLC 42,600$291,0000.10%
SABBY MANAGEMENT, LLC 268,400$1,833,0000.08%
Baker Brothers Advisors 769,230$5,254,0000.04%
NBW CAPITAL LLC 27,100$185,0000.04%
Plante Moran Financial Advisors, LLC 8,534$58,0000.04%
View complete list of TRANSITION THERAPEUTICS INC shareholders